Overview of clinical data for candesartan
pdf
Clinical trials of candesartan and the meta-analysis of their results are available for the following clinical conditions:
atrial fibrillation
patient with history of atrial fibrillation
(in overview of all prevention)
pdf
candesartan vs placebo :
CAPRAF (Tveit) ,2007
-
patients without history of AF (primary prevention)
(in overview of all prevention)
pdf
candesartan vs placebo :
CHARM (AF ancillary study) ,2005
-
heart failure
all type of patients
(in overview of all angiotensin-receptor blockers)
pdf
candesartan vs enalapril :
RESOLVD (candesartan alone) ,1999
-
candesartan vs placebo :
ARCH-J ,2003
-
CHARM-Alternative ,2003
-
Mitrovic et al. ,2003
-
SPICE ,2000
-
STRETCH ,1999
-
candesartan+ACE inhibitor vs ACE inhibitor only :
CHARM-Added ,2003
-
RESOLVD association ,1999
-
patients already receiving ACE inhibitor
(in overview of all angiotensin-receptor blockers)
pdf
candesartan+ACE inhibitor vs ACE inhibitor only :
CHARM-Added ,2003
-
patients intolerant to ACE inhibitors
(in overview of all angiotensin-receptor blockers)
pdf
candesartan vs placebo :
CHARM-Alternative ,2003
-
SPICE ,2000
-
patients previously untreated with ACE inhibitors
(in overview of all angiotensin-receptor blockers)
pdf
candesartan vs placebo :
ARCH-J ,2003
-
patients with preserved-LVEF heart failure
(in overview of all angiotensin-receptor blockers)
pdf
candesartan vs placebo :
CHARM preserved ,2003
-
patients with preserved-LVEF heart failure
(in overview of all inhibition of the renin-angiotensin system (ACEI or ARB))
pdf
candesartan vs placebo :
CHARM preserved ,2003
-
heart failure with preserved LVEF
all type of patients
(in overview of all All mecanism)
pdf
candesartan vs placebo :
CHARM preserved ,2003
-
hypertension
all diseases requiring ACEi (HF, CHD, HT,...)
(in overview of all angiotensin-receptor blockers)
pdf
candesartan vs placebo :
SCOPE ,2003
-
Candesartan vs usual care :
HIJ-CREATE ,2009
-
all type of patient
(in overview of all anti hypertensive agent)
pdf
candesartan vs placebo :
SCOPE ,2003
-
patients undergoing dialysis
(in overview of all anti hypertensive agent)
pdf
candesartan vs usual care :
Takahashi et al ,2006
-
Suzuki et al ,2008
-
subjects with pre-hypertension
(in overview of all anti hypertensive agent)
pdf
candesartan vs placebo :
TROPHY ,2006
-
miscellaneous
all type of patients
(in overview of all angiotensin-receptor blockers)
pdf
candesartan vs placebo :
SCOPE ,2003
-
TROPHY ,2006
-
patients at high risk for cardiovascular events
all type of patients
(in overview of all angiotensin-receptor blockers)
pdf
candesartan vs placebo :
SCOPE ,2003
-
Entry terms: 1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate, candesartan cilexetil, 1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate, TCV 116, TCV-116, Atacand, Astra brand of candesartan cilexetil, Takeda brand of candesartan cilexetil, Blopress, Kenzen, Promed brand of candesartan cilexetil, Amias, AstraZeneca brand of candesartan cilexetil, Parapres, Almirall brand of candesartan cilexetil, candesartan, 2-ethoxy-7-carboxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylbenzimidazole, CV 11974, CV11974, CV-11974
See also relatic topics:
Search candesartan clinical trials in
Pubmed
Search candesartan clinical trials in
ClinicalTrials.gov
Search candesartan clinical trials in
Wikipedia
Search candesartan in
drugs.com
browse_trt3
|